Phase I Trials

A faster track to measuring impact.

IQVIA can help you track the impact of new drugs and establish proof of concept faster with innovative early clinical development strategies, including hybrid studies involving both healthy volunteers and patients.

Professional and NHS doctor looking at computer

Changing the equation for early clinical development

By using a network of highly specialized sites who perform early phase trials, IQVIA gives you the flexibility to find and focus on geographies, sites and methods best suited to your specific study. It's an approach that lets you continue to drive scientific breakthroughs and control costs, without compromising on efficiency or quality. 

The IQVIA global network

All IQVIA network sites receive a Quality Assurance (QA) Audit and Medical Safety Assessment against ethical, regulatory, medical and quality standards. The assessment also guides early phase clinical trial designs and types of drug candidates that can be investigated at each site. In addition to ensuring rigorous safety and quality standards, the IQVIA network also gives you important operational advantages. It’s a choice that lets you

  • Work with one dedicated partner – no need for multiple vendors
  • Target diverse populations and geographies
  • Execute healthy volunteer, patient, or hybrid first-in-human and proof-of-concept studies
  • Access IQVIA's expertise, including our Therapeutic Centers of Excellence for oncology and neurology
  • Outsource management of site negotiations and contracts

Related solutions

Contact Us